In a 55 year old female breast cancer patient whose tumor cells are estrogen sensitive, which of the following chemotherapeutic agents is most likely to control the breast tumor growth but predispose the patient to endometrial cancer? Group of answer choices Tamoxifen Raloxifene Fulvestrant Bexarotene
In a 55 year old female breast cancer patient whose tumor cells are estrogen sensitive, which of the following chemotherapeutic agents is most likely to control the breast tumor growth but predispose the patient to endometrial cancer? Group of answer choices Tamoxifen Raloxifene Fulvestrant Bexarotene
Chapter15: Adult And Pediatric Dosages Based On Body Weight
Section: Chapter Questions
Problem 7.2P
Related questions
Concept explainers
Question
In a 55 year old female breast cancer patient whose tumor cells are estrogen sensitive, which of the following chemotherapeutic agents is most likely to control the breast tumor growth but predispose the patient to endometrial cancer?
Group of answer choices
Tamoxifen
Raloxifene
Fulvestrant
Bexarotene
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 3 steps
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.Recommended textbooks for you
Comprehensive Medical Assisting: Administrative a…
Nursing
ISBN:
9781305964792
Author:
Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa
Publisher:
Cengage Learning
Comprehensive Medical Assisting: Administrative a…
Nursing
ISBN:
9781305964792
Author:
Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa
Publisher:
Cengage Learning
Essentials of Pharmacology for Health Professions
Nursing
ISBN:
9781305441620
Author:
WOODROW
Publisher:
Cengage